Ketogen is a biotechnology company developing a new generation of small molecule, hybrid therapeutics for the treatment of CNS disorders with a focus on orphan, drug-resistant epilepsy disorders.
Ketogen Pharma Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.ketogen.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
AddressOntarioCanada
Ontario
Canada
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]